Picraline TN4784
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
A series of a hydroxy substituted derivatives 21-28 at C-17 of the Picraline-type alkaloids have been derived as having potent SGLT inhibitory activity.
CAS nr:
2671-32-1
Purity:
98%
Molecular Weight:
410,5
SMILES:
COC(=O)[C@]1(COC(C)=O)[C@H]2C[C@@H]3N(C\C2=C\C)[C@@H]2C[C@@]11c4ccccc4N[C@@]31O2
Formula:
C23H26N2O5
Pathway:
GPCR/G Protein
Target:
SGLT


